Categories: Wall Street Journal

1/12/2018

Stem cells for knee problems: WSJ doesn’t explore costs, harms, alternatives

12/20/2017

Antibiotics could ‘dramatically reduce’ STIs, STAT says, though findings apply to small group of men

11/6/2017

WSJ’s look at stent study: Solid reporting, with room for more detail on costs and risks

10/27/2017

Plenty of context, but evidence was AWOL in WSJ story on uterine fibroid treatment

10/17/2017

WSJ wisely reports on Ebola vaccines: ‘It is unknown…what antibody levels are needed to protect patients’

6/28/2017

WSJ’s look at digital therapy covers a lot of ground–except potential downsides

4/26/2017

WSJ story on prostate procedure: No independent sources were quoted

2/21/2017

In story on vision-improving headset, WSJ left most important detail in the dark

11/30/2016

Thorough WSJ report on insomnia treatments would have benefited from cost comparison

11/11/2016

Fast-track treatment for hip fractures: WSJ story needed some figures to back up the claims